Literature DB >> 23730062

Assessment of the Effects of Curacel and Bone Wax on the Acute Oroantral Opening Site by means of Computer Tomography and Histopathology.

Mehtap Muglali1, Ahmet Ozak, Murat Yarım, Mehmet Selim Nural, Nukhet Celebi, Tolga Aksoz.   

Abstract

PURPOSE: In this study, the effects of Curacel TM oxidized regenerated cellulose and bone wax on the healing bone were compared to each other by means of CT based bone density measurement and histopathological evaluation.
METHODS: The bone density measurements of the control group were significantly higher than those of both Curacel and bone wax groups.
RESULTS: There was no significant difference between Curacel and bone wax. Histopathologically, the bone wax group showed more osteoblastic activation than Curacel group. For all measurement parameters (osteoblastic activation, osteoclastic activation, fibrous connective tissue, osseous trabeculae), Curacel and bone wax groups had worse results than control group. It is concluded that Curacel has no superiority over bone wax in terms of osseous healing in the oroantral region. There is no need to use oxidized regenerated cellulose or bone wax for small oroantral openings since the healing is better without any intervention. In addition, bone density measurement and histopathological evaluation were consistent in terms of osseous healing of the oroantral opening.

Entities:  

Keywords:  Bone wax; Curacel; Oroantral communication; Oxidized regenerated cellulose; Wound healing

Year:  2011        PMID: 23730062      PMCID: PMC3386401          DOI: 10.1007/s12663-011-0281-2

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  34 in total

1.  Bioabsorbable root analogue for closure of oroantral communications after tooth extraction: a prospective case-cohort study.

Authors:  Kaya Thoma; Gion F Pajarola; Klaus W Grätz; Patrick R Schmidlin
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-02-28

2.  Maxillary molar sinus floor intrusion at the time of dental extraction.

Authors:  Ole T Jensen; Carl Brownd; David Baer
Journal:  J Oral Maxillofac Surg       Date:  2006-09       Impact factor: 1.895

3.  Tantalum foil used in closing antro-oral fistulas.

Authors:  E J McCLUNG; J E CHIPPS
Journal:  U S Armed Forces Med J       Date:  1951-08

4.  Incidence of oral sinus communications in 389 upper thirmolar extraction.

Authors:  Marta del Rey-Santamaría; Eduard Valmaseda Castellón; Leonardo Berini Aytés; Cosme Gay Escoda
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2006-07-01

5.  Closure of oroantral communications using a pedicled buccal fat pad graft.

Authors:  Y Hanazawa; K Itoh; T Mabashi; K Sato
Journal:  J Oral Maxillofac Surg       Date:  1995-07       Impact factor: 1.895

6.  A clinical study on oroantral fistulae.

Authors:  O Güven
Journal:  J Craniomaxillofac Surg       Date:  1998-08       Impact factor: 2.078

7.  Radiographic comparison of osseous healing after maxillary sinusotomy performed with and without a periosteal pedicle.

Authors:  B H Choi; J H Yoo; K J Sung
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1996-10

8.  Osseous reactions to three hemostatic agents.

Authors:  J L Ibarrola; J E Bjorenson; B P Austin; H Gerstein
Journal:  J Endod       Date:  1985-02       Impact factor: 4.171

9.  Correlation between the development of an oroantral fistula and the size of the corresponding bony defect.

Authors:  N von Wowern
Journal:  J Oral Surg       Date:  1973-02

10.  Closure of oroantral communications using biodegradable polyurethane foam: a feasibility study.

Authors:  Susan H Visscher; Baucke van Minnen; Rudolf R M Bos
Journal:  J Oral Maxillofac Surg       Date:  2010-01-15       Impact factor: 1.895

View more
  1 in total

1.  Treatment of Oroantral Communication Using the Lateral Palatal Sliding Flap Technique.

Authors:  Fernando Salimon Ribeiro; Cassio Torres de Toledo; Michele Romero Aleixo; Maria Cristina Durigan; Willian Corrêa da Silva; Samanta Kelen Bueno; Ana Emília Farias Pontes
Journal:  Case Rep Med       Date:  2015-05-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.